143 related articles for article (PubMed ID: 35961818)
21. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
[TBL] [Abstract][Full Text] [Related]
22. Image-defined risk factors in localized thoracic neuroblastoma and ganglioneuroma.
Butzer SK; Krug B; Reisberg M; Fuchs J; Warmann SW; Hubertus J; Körber F; Berthold F; Simon T; Hero B
Pediatr Blood Cancer; 2023 Oct; 70(10):e30605. PubMed ID: 37534915
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of radiomic features from computed tomography for preoperative classification of neuroblastic tumors in children.
Zhao L; Shi L; Huang SG; Cai TN; Guo WL; Gao X; Wang J
BMC Pediatr; 2023 May; 23(1):262. PubMed ID: 37226234
[TBL] [Abstract][Full Text] [Related]
24. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.
Coco S; Defferrari R; Scaruffi P; Cavazzana A; Di Cristofano C; Longo L; Mazzocco K; Perri P; Gambini C; Moretti S; Bonassi S; Tonini GP
J Pathol; 2005 Nov; 207(3):346-57. PubMed ID: 16178058
[TBL] [Abstract][Full Text] [Related]
25. Minimally invasive surgery for neuroblastic tumours: A SIOPEN multicentre study: Proposal for guidelines.
Gabra HO; Irtan S; Cross K; Lobos P; Froeba-Pohl A; Pio L; Virgone C; Guillén Burrieza G; Gómez Chacón Villalba J; Riccipetitoni G; Guérin F; Nightingale M; Heloury Y; Faraj S; Leclair M; Scalabre A; Mattioli G; Warmann SW; Fuchs J; Basta N; Bjørnland K; Matthyssens LE; Losty PD; Sarnacki S
Eur J Surg Oncol; 2022 Jan; 48(1):283-291. PubMed ID: 34489122
[TBL] [Abstract][Full Text] [Related]
26. Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.
Nezami BG; Modak S; Cardenas FI; Sarungbam J; Sirintrapun SJ; Gopalan A; Chen Y; Al-Ahmadie H; Fine SW; Reuter VE; Tickoo SK
Pediatr Blood Cancer; 2023 Aug; 70(8):e30434. PubMed ID: 37243318
[TBL] [Abstract][Full Text] [Related]
27. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
[TBL] [Abstract][Full Text] [Related]
28. Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach.
Choi JH; Ro JY
Semin Diagn Pathol; 2022 Mar; 39(2):120-130. PubMed ID: 34167847
[TBL] [Abstract][Full Text] [Related]
29. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
30. Retrospective accuracy analysis of MRI based lesion size measurement in neuroblastic tumors: which sequence should we choose?
Gassenmaier S; Tsiflikas I; Maennlin S; Urla C; Warmann SW; Schaefer JF
BMC Med Imaging; 2020 Sep; 20(1):105. PubMed ID: 32912148
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
Okamatsu C; London WB; Naranjo A; Hogarty MD; Gastier-Foster JM; Look AT; LaQuaglia M; Maris JM; Cohn SL; Matthay KK; Seeger RC; Saji T; Shimada H
Pediatr Blood Cancer; 2009 Oct; 53(4):563-9. PubMed ID: 19530234
[TBL] [Abstract][Full Text] [Related]
32. Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
Wu W; Xu WJ; Liu JB; Sun J; Huang YM; Lv ZB
Math Biosci Eng; 2019 Aug; 16(6):7217-7229. PubMed ID: 31698611
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.
Angelini P; London WB; Cohn SL; Pearson AD; Matthay KK; Monclair T; Ambros PF; Shimada H; Leuschner I; Peuchmaur M; Irwin MS; Baruchel S
Eur J Cancer; 2012 May; 48(8):1185-91. PubMed ID: 22137163
[TBL] [Abstract][Full Text] [Related]
34. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.
Lonergan GJ; Schwab CM; Suarez ES; Carlson CL
Radiographics; 2002; 22(4):911-34. PubMed ID: 12110723
[TBL] [Abstract][Full Text] [Related]
35. Computer-assisted rescue of the inferior mesenteric artery in a child with a giant ganglioneuroblastoma: A case report.
Xiu WL; Liu J; Zhang JL; Su N; Wang FJ; Hao XW; Wang FF; Dong Q
World J Gastrointest Surg; 2023 May; 15(5):984-991. PubMed ID: 37342847
[TBL] [Abstract][Full Text] [Related]
36. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of fluorodeoxyglucose positron emission tomography/computed tomography for detection of a neuroblastic nodule in a ganglioneuroblastoma: a case report.
Takeda Y; Sano H; Kawano A; Mochizuki K; Takahashi N; Kobayashi S; Ohara Y; Tasaki K; Hosoya M; Kikuta A
J Med Case Rep; 2018 May; 12(1):119. PubMed ID: 29720264
[TBL] [Abstract][Full Text] [Related]
38. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.
Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Galmiche-Rolland L; Le Cossec C; Elie C; Canale S; Michon J; Valteau-Couanet D; Sarnacki S
Pediatr Blood Cancer; 2015 Sep; 62(9):1543-9. PubMed ID: 25820608
[TBL] [Abstract][Full Text] [Related]
39. Adrenal masses in children: Imaging, surgical treatment and outcome.
Emre Ş; Özcan R; Bakır AC; Kuruğoğlu S; Çomunoğlu N; Şen HS; Celkan T; Tekant GT
Asian J Surg; 2020 Jan; 43(1):207-212. PubMed ID: 30962018
[TBL] [Abstract][Full Text] [Related]
40. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
